Diamines & Chemicals Limited has informed the Exchange about statement of deviation(s) or variation(s) under Reg. 32
DIAMINESQ · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Diamines and Chemicals Limited has filed a quarterly Reg. 32(1) disclosure for the quarter ended December 31, 2025, covering funds raised through a preferential issue of convertible warrants. On October 1, 2024, the company allotted 906,390 convertible warrants at Rs. 552 per warrant, with a total potential issue size of Rs. 50.58 Cr; however, only Rs. 12.51 Cr (25% of the issue) was received upfront as subscription money. The full Rs. 12.51 Cr has been utilised towards capital expenditure, working capital requirements, acquisitions, investment in technology, and general corporate purposes. The company confirms there is no deviation or variation in the use of funds, and both the audit committee and auditors have no comments.
This is a routine SEBI compliance filing confirming that warrant issue proceeds have been deployed strictly as originally intended, with no misuse or deviation — a neutral-to-positive signal for shareholders on fund management discipline.